Peter Jüni to Ontario
This is a "connection" page, showing publications Peter Jüni has written about Ontario.
Connection Strength
0.056
-
Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial. Circulation. 2019 11 19; 140(21):1693-1702.
Score: 0.030
-
Protocol for a randomised controlled trial evaluating the effects of providing essential medicines at no charge: the Carefully seLected and Easily Accessible at No Charge Medicines (CLEAN Meds) trial. BMJ Open. 2017 06 12; 7(5):e015686.
Score: 0.026